| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |